Atossa Therapeutics (ATOS) Depreciation and Depletion (2012 - 2026)
Atossa Therapeutics (ATOS) reported Depreciation and Depletion of $4,000 for Q2 2026, unchanged from $4,000 a year earlier and unchanged from the prior quarter.
Atossa Therapeutics (ATOS) Depreciation and Depletion (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Atossa Therapeutics' Depreciation and Depletion came in at $16,000, unchanged year-over-year; for FY2025, it came in at $16,000, down 5.9% from FY2024.
- Depreciation and Depletion has a five-year compound annual growth rate of -3.4% (FY2020 to FY2025).
- By year, Depreciation and Depletion came in at $17,000 in FY2024 (-26.1%), $23,000 in FY2023 (+187.5%), $8,000 in FY2022 (-20.0%) and $10,000 in FY2021 (-47.4%).
- Five-year quarterly Depreciation and Depletion spans a low of $3,000 in Q1 2023 and a high of $14,000 in Q4 2023.
- Year over year, Depreciation and Depletion gained in 1 of the last eight quarters, with an average decline of 7.3%.
- The high point for year-over-year Depreciation and Depletion in five years was Q1 2024 (growth of 66.7%); the low point was Q4 2024 (a decline of 71.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4,000 (Q1 2026), $4,000 (Q4 2025) and $4,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Atossa Therapeutics | 23.35 Mn | 23.35 Mn | - | 4,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,000.00 |
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Mar 31, 2018 | 2,725.00 |
| Dec 31, 2017 | 2,968.00 |
| Sep 30, 2017 | 4,554.00 |
| Mar 31, 2017 | 9,662.00 |
| Sep 30, 2016 | 29,698.00 |
| Jun 30, 2016 | 32,734.00 |
Atossa Therapeutics Depreciation and Depletion API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ATOS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-depletion", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();